Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity
As regioisomers/bioisosteres of 1a, a 4-phenylbenzamide tranylcypromine (TCP) derivative previously disclosed by us, we report here the synthesis and biological evaluation of some (hetero)arylbenzoylamino TCP derivatives 1b-6, in which the 4-phenyl moiety of 1a was shifted at the benzamide C3 positi...
Saved in:
Main Authors: | Rossella Fioravanti (Author), Veronica Rodriguez (Author), Jonatan Caroli (Author), Ugo Chianese (Author), Rosaria Benedetti (Author), Elisabetta Di Bello (Author), Beatrice Noce (Author), Clemens Zwergel (Author), Davide Corinti (Author), Dolores Viña (Author), Lucia Altucci (Author), Andrea Mattevi (Author), Sergio Valente (Author), Antonello Mai (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials
by: Beatrice Noce, et al.
Published: (2023) -
LSD1 inhibition by tranylcypromine hydrochloride reduces alkali burn-induced corneal neovascularization and ferroptosis by suppressing HIF-1α pathway
by: Qian Deng, et al.
Published: (2024) -
3-Chloro-N'-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy
by: Federica Sarno, et al.
Published: (2018) -
Strategies that regulate LSD1 for novel therapeutics
by: Meng Li, et al.
Published: (2024) -
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group
by: Pasquale Linciano, et al.
Published: (2021)